![]() |
|
Information For:
|
Revision BulletinGeneral Chapter <671>Containers – Performance TestingDecember 1, 2007The 2nd Supplement to USP 30, recently published and official on December 1, 2007, included a revision to General Chapter <671> Containers – Performance Testing. USP received two formal appeals and two informal requests from pharmaceutical companies, all asking that USP cancel and retract the revised chapter due to the additional Phase 2 test and other changes made to <671> after it had appeared in Pharmacopeial Forum (PF). After consideration of these requests and appeals, USP and the Executive Committee of the Council of Experts have determined that the sections of <671> containing these additional changes will be retracted and returned to PF for additional review and comment (see Intent to Revise Statement). As a result of this determination, General Chapter <671> Containers – Performance Testing will become official as of December 1, 2007, as it was originally published in PF 32(4). A link to this version of the General Chapter is provided below. This text will appear in print in the First Supplement to USP 31–NF 26. Should you have any questions about General Chapter <671>, please contact Susan S. de Mars, Chief Legal Officer (301–816–8296 or ). What's NewPublic comments sought on high priority excipient monographs (07/01/09) Public comments sought on General Notices (07/01/09) PF 35(4) IRAs and Errata (06/30/09) New Official Text for the month of June (06/24/09) Pending Standards for June (06/26/09) Notice of Heparin Stage 2 Interim Revision Announcements (06/24/09) PF 35(4), July-August 2009: Highlights and Stimuli Articles (06/24/09) Modafinil: Notice of Intent to Revise (06/19/09) Excipients e-Newsletter (06/16/09) Related Resources |
||||||||||||||||||||||||||||
Copyright © 2009 The United States Pharmacopeial Convention
|
|||||||||||||||||||||||||||||